Kingsview Wealth Management LLC Makes New $10.34 Million Investment in Merck KGaA $MKGAF

Posted by Casey Walker on Aug 29th, 2026

Kingsview Wealth Management LLC bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 80,440 shares of the company’s stock, valued at approximately $10,337,000. Kingsview Wealth Management LLC owned 0.06% of Merck KGaA as of its most recent SEC filing.

Several other large investors have also modified their holdings of MKGAF. Gables Capital Management Inc. purchased a new position in shares of Merck KGaA during the 2nd quarter worth $2,095,000. Diversify Advisory Services LLC purchased a new stake in Merck KGaA in the 2nd quarter valued at about $3,810,000. Danske Bank A S purchased a new stake in Merck KGaA in the 2nd quarter valued at about $276,535,000. Danica Pension Livsforsikringsaktieselskab purchased a new stake in Merck KGaA in the 2nd quarter valued at about $25,541,000. Finally, BOK Financial Private Wealth Inc. acquired a new position in Merck KGaA in the second quarter valued at about $523,000. Institutional investors and hedge funds own 0.10% of the company’s stock.

Merck KGaA Trading Up 3.8%

Shares of MKGAF stock opened at $164.12 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The firm has a market cap of $21.21 billion, a PE ratio of 25.06 and a beta of 0.96. The company has a 50-day moving average of $163.35 and a two-hundred day moving average of $149.06. Merck KGaA has a 1-year low of $116.68 and a 1-year high of $175.56.

Merck KGaA Company Profile

(Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.